Skip to content

Facilitating shared decision-making in geriatric oncology - together, ethically and responsibly.

Facilitating shared decision-making in geriatric oncology - together, ethically and responsibly. - PartEngO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028470
Enrollment
141
Registered
2022-03-10
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemato-oncological tumors Solid tumors Brain metastases from different primary tumors

Interventions

Group 1: Pre (Control group): Standard care (physician's’ counseling regarding information and decision about therapy). Group 2: Post (Intervention Group): Inclusion of geriatric assessment (physi

Sponsors

Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with an initial diagnosis or recurrence or advanced disease stage of hemato-oncological and solid tumors or with brain metastases of different primary tumors faced with the decision for further therapeutic procedure.

Exclusion criteria

Exclusion criteria: Incapacity to consent/legal guardianship, diagnosis of severe dementia, acute mental illness, highly palliative situation with life expectancy < 3 months.

Design outcomes

Primary

MeasureTime frame
Shared Decision Making: Extent of patient involvement in Decision Making as Measured by the Multifocal Approach to the 'sharing' in Shared Decision Making' (MAPPIN'SDM) Instrument (Patient-Based Assessment: MAPPIN-Qpatient).

Secondary

MeasureTime frame
Perception of patient participation by physician (MAPPIN-Qphysician). Agreement of MAPPIN ratings between MAPPIN-Qpatient and MAPPIN-Qphysician. Decision regret, patient-reported health-related disease-specific quality of life, ADL, IADL, treatment discontinuation, clinical course. Process evaluation regarding feasibility and use of resources as well as acceptance and potential benefit from the perspectives of all stakeholders.

Countries

Germany

Contacts

Public ContactHeike Schmidt

Institut für Gesundheits- und Pflegewissenschaften und Universitätsklinik und Poliklinik für Strahlentherapie, Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg

heike.schmidt2@uk-halle.de0345 557-4194

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026